In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Advanced Research Technologies brings in $Cdn6mm

Executive Summary

Advanced Research Technologies (molecular imaging for cancer diagnostics) raised $Cdn6mm ($5.5mm) through the private placement to Oppenheimer Funds and other existing investors of 46mm 7% preferred shares at $Cdn0.13 each. The shares convert anytime into common stock at a rate of 0.95 common shares for each preferred share.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies